|
Volumn 25, Issue 2, 2004, Pages 493-502
|
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
9-DEOXY-DELTA-9-PROSTAGLANDIN D2;
CYCLOOXYGENASE 2;
DRUG DERIVATIVE;
GLIAL FIBRILLARY ACIDIC PROTEIN;
ISOENZYME;
MEMBRANE PROTEIN;
NEUROFILAMENT PROTEIN;
NEUROFILAMENT PROTEIN NF 68;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PROSTAGLANDIN D2;
PROSTAGLANDIN J2;
PROSTAGLANDIN SYNTHASE;
PTGS2 PROTEIN, HUMAN;
ROSIGLITAZONE;
VIMENTIN;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
CELL CYCLE G2 PHASE;
CELL DIFFERENTIATION;
CELL NUCLEUS;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
GENE EXPRESSION;
GENETICS;
GLIOBLASTOMA;
HUMAN;
IMMUNOLOGY;
METABOLISM;
PATHOLOGY;
UPREGULATION;
APOPTOSIS;
CELL DIFFERENTIATION;
CELL NUCLEUS;
CELL PROLIFERATION;
CYCLOOXYGENASE 2;
G2 PHASE;
GENE EXPRESSION;
GLIAL FIBRILLARY ACIDIC PROTEIN;
GLIOBLASTOMA;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
NEUROFILAMENT PROTEINS;
PPAR GAMMA;
PROSTAGLANDIN D2;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
THIAZOLIDINEDIONES;
TUMOR CELLS, CULTURED;
UP-REGULATION;
VIMENTIN;
|
EID: 11344266106
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (64)
|
References (0)
|